May 3-4, 2021 | 10:00AM EDT | 2:00PM UTC | 4:00PM CEST*
*Program is in development and subject to change
Synthetic Biology tools and principles have matured tremendously over the last decade and have reached extraordinary levels of sophistication, both in eukaryotic and prokaryotic systems. Synthetic biology as a therapeutic modality is starting to enter multiple clinical studies and has the potential to have a significant impact on medicine across a wide range of diseases (e.g., metabolic, immune-mediated, cancer, and neurologic diseases). This Keystone Symposia conference will delve into the field of synthetic biology with a special emphasis on its applications to medicine. While there are conferences that capture synthetic biology in only a few talks mixed in among other various topics, there is a paucity of conferences focused on synthetic biology as drugs to treat disease.
However, due to the rapid pace of fundamental scientific advances along with an expanding number of biotechnology companies and emerging clinical studies with synthetic biology at their core, this conference will be highly relevant for a wide audience of scientists both from academia and industry. In addition, other meetings in this field have a highly technology-driven focus on synthetic biology techniques with relatively little attention given to biological and medical context. Ultimately, this Keystone Symposia conference should inspire researchers from diverse backgrounds to discuss synthetic biology via many new angles.
Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD
Abstract Submission
‣ For Short Talk Consideration: March 22, 2021
‣ For Poster Booth: April 19, 2021
ePoster / SciTalk Submission: April 22, 2021
Financial Aid Application: April 19, 2021
*Abstract submission is required in order to submit an ePoster and/or Scitalk
#VKSSynthBio21
Graduate students and postdoctoral fellows, as well as individuals from low- and middle- income countries (all career stages) working in science and medicine-related fields, are eligible to apply for a FREE registration code.
Find out more about financial aid opportunities here!
Showcase your work to global audiences on the eSymposia platform!
Submit your abstract for the opportunity to be selected for a short talk presentation alongside field leaders on the meeting program! See Abstract Deadline for Short Talk Consideration
ePoster presenters will be provided with their own dedicated page on the event website to display their work in multiple formats and interact with meeting participants. ePoster features include:
To submit your work for an ePoster presentation, and to be considered for short talk selection, go to the “Submit an Abstract” tab on the event homepage.
Martin Fussenegger
ETH Zürich, Switzerland
Matthew Chang
National University of Singapore, Singapore
Yvonne Y. Chen
University of California, Los Angeles, USA
Virginia W. Cornish
Columbia University, USA
Luis Ángel Fernández
National Center of Biotechnology - CSIC, Spain
Martin Fussenegger
ETH Zürich, Switzerland
Roger Geiger
Institute for Research in Biomedicine, Switzerland
Jeff Hasty
University of California, San Diego, USA
David Hava
Synlogic, Inc., USA
Howard L. Kaufman
Massachusetts General Hospital, USA
Samira Kiani
University of Pittsburgh School of Medicine, USA
Gary K. Lee
Senti Biosciences, USA
Joshua N. Leonard
Northwestern University, USA
Cammie Lesser
Massachusetts General Hospital, USA
Jose M. Lora
enGene, Inc, USA
Timothy K. Lu
Massachusetts Institute of Technology, USA
Francisco J. Quintana
Harvard Medical School, USA
Owen J. L. Rackham
Duke-NUS, Singapore
Kole T. Roybal
University of California, San Francisco, USA
Zhen Xie
Tsinghua University, China
Funding for this conference was made possible (in part) by 1R13EB029305 - 01 from the National Institute of Biomedical Imaging and Bioengineering. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.
This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.